Mild Dose

Amylin Pharma (AMLN) is a stock I had bought earlier in the $14 range and before getting out in the low 20s.

After successive failures (how's that for some word play), the stock has been punished handsomely. The current price provides a good entry point, and I bought 50% of my allocation for AMLN (1000 shares). I'm keeping a tight stop ($10.24).

It warms the cockles of my heart to know I paid 2/3rd the price paid by Icahn.

blog comments powered by Disqus